Oxetorone
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Oxetorone (INN), as oxetorone fumarate (USAN) (brand names Nocertone, Oxedix), is a serotonin antagonist, antihistamine, and alpha blocker used as an antimigraine drug.[1][2][3][4]
Association with hyperprolactinemia has been described.[5]
References
- ↑ C.R. Ganellin; David J. Triggle (21 November 1996). Dictionary of Pharmacological Agents. CRC Press. pp. 1493–. ISBN 978-0-412-46630-4.
- ↑ William Andrew Publishing (22 October 2013). Pharmaceutical Manufacturing Encyclopedia, 3rd Edition. Elsevier. pp. 2935–. ISBN 978-0-8155-1856-3.
- ↑ C.J. van Boxtel; B. Santoso; I.R. Edwards (6 August 2008). Drug Benefits and Risks: International Textbook of Clinical Pharmacology – Revised 2nd Edition. IOS Press. pp. 699–. ISBN 978-1-60750-345-3.
- ↑ Massiou H (2000). “[Prophylactic treatments of migraine]”. Rev. Neurol. (Paris) (in French). 156 Suppl 4: 4S79–86. PMID 11139754.
- ↑ Pradalier A (December 1996). “Hyperprolactinaemia and depression induced by oxetorone”. Cephalalgia. 16 (8): 560–1. doi:10.1046/j.1468-2982.1996.1608560.x. PMID 8980859.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH